Vitamin D status and incident cardiovascular disease and all-cause mortality: A general population study

Endocrine

Volumn 43, Issue 3, 2013, Pages 618-625

  Skaaby, Tea ^a   Husemoen, Lise Lotte Nystrup ^a   Pisinger, Charlotta ^a   Jørgensen, Torben ^a,b,c   Thuesen, Betina Heinsbæk ^a   Fenger, Mogens ^d   Linneberg, Allan ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c AALBORG UNIVERSITY   (Denmark)

^d HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Cardiovascular disease; Ischemic heart disease; Mortality; Prospective; Stroke; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE REGISTRY; EDUCATIONAL STATUS; FEMALE; HEALTH STATUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; ISCHEMIC HEART DISEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHYSICAL ACTIVITY; POPULATION RESEARCH; PRIORITY JOURNAL; SEASONAL VARIATION; SMOKING; VITAMIN BLOOD LEVEL;

EID: 84877873310     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9805-x     Document Type: Article

References (42)

1. M.F. Holick, Vitamin D deficiency. N. Engl. J. Med. 357, 266-281 (2007)
2. P. Autier, S. Gandini, Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 167, 1730-1737 (2007)
3. N. Vilarrasa, J. Vendrell, J. Maravall, I. Elio, E. Solano, J.P. San, I. Garcia, N. Virgili, J. Soler, J.M. Gomez, Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine 38, 235-242 (2010)
4. M. Rotondi, L. Chiovato, Vitamin D deficiency in patients with Graves' disease: probably something more than a casual association. Endocrine (2012). doi: 10.1007/s12020-012-9776-y
5. Y.C. Li, G. Qiao, M. Uskokovic, W. Xiang, W. Zheng, J. Kong, Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J. Steroid Biochem. Mol. Biol. 89-90, 387-392 (2004)
6. J.H. Lee, J.H. O'Keefe, D. Bell, D.D. Hensrud, M.F. Holick, Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J. Am. Coll. Cardiol. 52, 1949-1956 (2008)
7. M. Ohsawa, T. Koyama, K. Yamamoto, S. Hirosawa, S. Kamei, R. Kamiyama, 1alpha,25-dihydroxyvitamin D(3) and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL. Circulation 102, 2867-2872 (2000)
8. K. Muller, P.M. Haahr, M. Diamant, K. Rieneck, A. Kharazmi, K. Bendtzen, 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine 4, 506-512 (1992)
9. K.C. Chiu, A. Chu, V.L. Go, M.F. Saad, Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am. J. Clin. Nutr. 79, 820-825 (2004)
10. N.C. Bozkurt, E. Cakal, M. Sahin, E.C. Ozkaya, H. Firat, T. Delibasi, The relation of serum 25-hydroxyvitamin-D levels with severity of obstructive sleep apnea and glucose metabolism abnormalities. Endocrine 41, 518-525 (2012)
11. A.D. Lopez, C.D. Mathers, M. Ezzati, D.T. Jamison, C.J. Murray, Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367, 1747-1757 (2006)
12. S. Jaimungal, K. Wehmeier, A.D. Mooradian, M.J. Haas, The emerging evidence for vitamin D-mediated regulation of apolipoprotein A-I synthesis. Nutr. Res. 31, 805-812 (2011)
13. A.S. Kim, S.C. Johnston, Global variation in the relative burden of stroke and ischemic heart disease. Circulation 124, 314-323 (2011)
14. J. Kendrick, G. Targher, G. Smits, M. Chonchol, 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 205, 255-260 (2009)
15. E.S. Ford, G. Zhao, J. Tsai, C. Li, Vitamin D and all-cause mortality among adults in USA: findings from the National Health and Nutrition Examination Survey Linked Mortality Study. Int. J. Epidemiol. 40, 998-1005 (2011)
16. S. Pilz, H. Dobnig, G. Nijpels, R.J. Heine, C.D. Stehouwer, M.B. Snijder, R.M. van Dam, J.M. Dekker, Vitamin D and mortality in older men and women. Clin. Endocrinol. (Oxf) 71, 666-672 (2009)
17. A. Kilkkinen, P. Knekt, A. Aro, H. Rissanen, J. Marniemi, M. Heliovaara, O. Impivaara, A. Reunanen, Vitamin D status and the risk of cardiovascular disease death. Am. J. Epidemiol. 170, 1032-1039 (2009)
18. W. Messenger, C.M. Nielson, H. Li, T. Beer, E. Barrett-Connor, K. Stone, J. Shannon, Serum and dietary vitamin D and cardiovascular disease risk in elderly men: A prospective cohort study. Nutr. Metab. Cardiovasc. Dis. 22, 856-863 (2011)
19. M.L. Melamed, E.D. Michos, W. Post, B. Astor, 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch. Intern. Med. 168, 1629-1637 (2008)
20. N.C. Grandi, L.P. Breitling, H. Brenner, Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev. Med. 51, 228-233 (2010)
21. L. Wang, J.E. Manson, Y. Song, H.D. Sesso, Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann. Intern. Med. 152, 315-323 (2010)
22. A.G. Pittas, M. Chung, T. Trikalinos, J. Mitri, M. Brendel, K. Patel, A.H. Lichtenstein, J. Lau, E.M. Balk, Systematic review: vitamin D and cardiometabolic outcomes. Ann. Intern. Med. 152, 307-314 (2010)
23. D.P. Trivedi, R. Doll, K.T. Khaw, Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326, 469 (2003)
24. M.B. Elamin, N.O. Abu Elnour, K.B. Elamin, M.M. Fatourechi, A.A. Alkatib, J.P. Almandoz, H. Liu, M.A. Lane, R.J. Mullan, A. Hazem, P.J. Erwin, D.D. Hensrud, M.H. Murad, V.M. Montori, Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 96, 1931-1942 (2011)
25. M.H. Olsen, T.W. Hansen, M.K. Christensen, F. Gustafsson, S. Rasmussen, K. Wachtell, H. Ibsen, C. Torp-Pedersen, P.R. Hildebrandt, N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population. Eur. Heart J. 28, 1374-1381 (2007)
26. T. Jorgensen, K. Borch-Johnsen, T.F. Thomsen, H. Ibsen, C. Glumer, C. Pisinger, A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur. J. Cardiovasc. Prev. Rehabil. 10, 377-386 (2003)
27. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech. Rep. Ser. 894, i-253 (2000)
28. G.D. Carter, R. Carter, J. Jones, J. Berry, How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme. Clin. Chem. 50, 2195-2197 (2004)
29. B. Thuesen, L. Husemoen, M. Fenger, J. Jakobsen, P. Schwarz, U. Toft, L. Ovesen, T. Jorgensen, A. Linneberg, Determinants of vitamin D status in a general population of Danish adults. Bone 50, 605-610 (2012)
30. T.F. Andersen, M. Madsen, J. Jorgensen, L. Mellemkjoer, J.H. Olsen, The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan. Med. Bull. 46, 263-268 (1999)
31. K. Juel, K. Helweg-Larsen, The Danish registers of causes of death. Dan. Med. Bull. 46, 354-357 (1999)
32. J.L. Anderson, H.T. May, B.D. Horne, T.L. Bair, N.L. Hall, J.F. Carlquist, D.L. Lappe, J.B. Muhlestein, Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am. J. Cardiol. 106, 963-968 (2010)
33. A.A. Ginde, R. Scragg, R.S. Schwartz, C.A. Camargo Jr, Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J. Am. Geriatr. Soc. 57, 1595-1603 (2009)
34. M.S. Hutchinson, G. Grimnes, R.M. Joakimsen, Y. Figenschau, R. Jorde, Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromso study. Eur. J. Endocrinol. 162, 935-942 (2010)
35. R.D. Semba, D.K. Houston, S. Bandinelli, K. Sun, A. Cherubini, A.R. Cappola, J.M. Guralnik, L. Ferrucci, Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur. J. Clin. Nutr. 64, 203-209 (2010)
36. T.J. Wang, M.J. Pencina, S.L. Booth, P.F. Jacques, E. Ingelsson, K. Lanier, E.J. Benjamin, R.B. D'Agostino, M. Wolf, R.S. Vasan, Vitamin D deficiency and risk of cardiovascular disease. Circulation 117, 503-511 (2008)
37. F. Hosseinpanah, M. Yarjanli, F. Sheikholeslami, M. Heibatollahi, P.S. Eskandary, F. Azizi, Associations between vitamin D and cardiovascular outcomes: Tehran Lipid and Glucose Study. Atherosclerosis 218, 238-242 (2011)
38. J. Hsia, G. Heiss, H. Ren, M. Allison, N.C. Dolan, P. Greenland, S.R. Heckbert, K.C. Johnson, J.E. Manson, S. Sidney, M. Trevisan, Calcium/vitamin D supplementation and cardiovascular events. Circulation 115, 846-854 (2007)
39. J.P. Wielders, F.A. Wijnberg, Preanalytical stability of 25(OH)-vitamin D3 in human blood or serum at room temperature: solid as a rock. Clin. Chem. 55, 1584-1585 (2009)
40. W.B. Grant, Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: implications for meta-analyses and setting vitamin D guidelines. Dermatoendocrinology 3, 199-204 (2011)
41. R. Jorde, M. Sneve, M. Hutchinson, N. Emaus, Y. Figenschau, G. Grimnes, Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am. J. Epidemiol. 171, 903-908 (2010)
42. G. Snellman, H. Melhus, R. Gedeborg, L. Byberg, L. Berglund, L. Wernroth, K. Michaelsson, Determining vitamin D status: a comparison between commercially available assays. PLoS ONE 5, e11555 (2010)